Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Teratomas Offer Source for Rebuilding Damaged Tissues

By LabMedica International staff writers
Posted on 19 Jul 2018
Muscle stem cells, which were derived from benign teratoma tumors, were found to demonstrate exceptional potential as starting material for rebuilding and maintaining damaged muscle tissues.

Investigators at the University of Minnesota Medical School (Minneapolis and Duluth, USA) created teratomas using undifferentiated pluripotent cells injected into immunodeficient mice, and isolated muscle stem cells from them. More...
Following purification by fluorescence-activated cell sorting (FACS) and transplantation into diseased muscles, mouse teratoma-derived myogenic progenitors demonstrated very high engraftment potential. As few as 40,000 cells could reconstitute about 80% of the tibialis anterior muscle volume.

Results published in the July 5, 2018, issue of the journal Cell Stem Cell revealed that newly generated fibers are innervated, expressed adult myosins, and ameliorated dystrophy-related force deficit and fatigability. Teratoma-derived myogenic progenitors also contributed quiescent PAX7+ muscle stem cells, enabling long-term maintenance of regenerated muscle and allowing muscle regeneration in response to subsequent injuries. Transcriptional profiling revealed that teratoma-derived myogenic progenitors underwent embryonic-to-adult maturation when they contributed to the stem cell compartment of regenerated muscle.

"The goal of this research was to seek in unexplored places a source of cells that, when transplanted, would rebuild skeletal muscle and demonstrate significant improvements in muscle strength and resilience," said senior author Dr. Michael Kyba, professor of pediatrics at the University of Minnesota Medical School.

In light of the ethical issues surrounding the source of human stem cells, teratomas are being looked at as an alternative source for research because they lack the potential to grow into functional human beings. Results of the current study suggest that teratomas are a rich and accessible source of potent transplantable skeletal muscle stem cells.

Related Links:
University of Minnesota Medical School


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.